Search For "zydus cadila"
Updated : 4 days, 21 hours ago IST
New Delhi [India], October 21 (ANI): As India achieved the milestone of vaccinating over 100 crore citizens on Thursday, we take look at the basket of vaccines developed, manufactured or in use in the country.
New Delhi [India], October 21 (ANI): Zydus Cadila's vaccine - ZyCoV-D is the first indigenously manufactured needle-free Covid-19 vaccine which is approved for children aged above 12 for emergency use in the country. Earlier, the Subject Experts Committee (SEC) has also recommended the Hy
Updated : 1 week, 2 days ago IST
New Delhi [India], October 16 (ANI): India will have a vaccine capacity of 28 crore doses this month, which includes 22 crore Serum Institute of India's Covishield and 6 crore doses of Bharat Biotech Biotech's Covaxin and production of 60 lakh Zydus Cadila's ZyCoV-D doses are also ready,
Updated : 1 week, 5 days ago IST
New Delhi [India], October 13 (ANI): As many as 60 lakh doses of Zydus Cadila's three-dose COVID-19 vaccine ZyCoV-D are ready after production, said government sources.
Updated : 2 weeks, 4 days ago IST
New Delhi [India], October 7 (ANI): Following the approval of the Zydus Cadila vaccine by the Drugs Controller General of India (DGCI) for emergency use, Dr VK Paul, Member (Health) of Niti Aayog on Thursday said that the vaccine will be administered through an applicator which will be us
Updated : 3 weeks, 1 day ago IST
New Delhi [India], October 4 (ANI): Negotiation over the pricing of COVID-19 vaccine ZyCov-D between the central government and Zydus Cadila are still underway. The final decision is expected by this week, as per the government sources.
New Delhi [India], October 3 (ANI): Once the COVID-19 vaccination drive for children commences in India, priority would be given to children with comorbidities however severe, said National Immunization Technical Advisory Group (NTAGI) Chairperson Dr NK Arora.
Updated : 1 month, 1 week ago IST
New Delhi [India], September 16 (ANI): Secretary, Department of Biotechnology, Government of India Dr Renu Swarup said that Drugs Controller General of India has given permission to Christian Medical College, Vellore to start a trial on the mixing of COVID-19 vaccines while adding that th
New Delhi [India], September 14 (ANI): The discussion on the pricing of Zydus Cadila's COVID-19 vaccine ZyCoV-D is underway, said Dr VK Paul, Member (Health) NITI Aayog on Tuesday.
New Delhi [India], September 12 (ANI): Considering the burden on healthcare and the expense of buying three doses, Zydus Cadila is planning to seek approval for the two-dose regimen of its needle-free COVID-19 vaccine, ZyCoV-D, days after the vaccine was approved by India's drugs regulator f
Updated : 1 month, 2 weeks ago IST
New Delhi [India], September 11 (ANI): Zydus Cadila's needle-free coronavirus vaccine-- ZyCoV-D-- is likely to be available by early October, sources told ANI on Saturday.
Updated : 1 month, 3 weeks ago IST
New Delhi [India], August 29 (ANI): Stating that India approved Zydus Cadila's DNA vaccine for emergency use in adults and children, Medanta Chairman and Managing Director Dr Naresh Trehan on Sunday cautioned against the re-opening of schools and said that since the vaccine is around the